Global Viral Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Viral Testing market report explains the definition, types, applications, major countries, and major players of the Viral Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Wuxi Pharmatech (Cayman)

    • Thermo Fisher Scientific

    • General Electric

    • Biospherix

    • BD

    • Sartorius

    • Bio-Rad Laboratories

    • Danaher

    • Roche

    • Agilent Technologies

    • QIAGEN International

    • Eurofins Scientific

    • Novogene Corporation

    • Lonza

    • Merck

    By Type:

    • Direct Fluorescent Antibody (DFA) Test

    • Immunochromatographic Assay

    • RT-PCR-Based Test

    • Agglutination Assay

    • Flow-Through Assay

    • Solid-Phase Assay

    By End-User:

    • Laboratory

    • Hospital

    • Home Care

    • Academic Institute

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Viral Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Viral Testing Outlook to 2028- Original Forecasts

    • 2.2 Viral Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Viral Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Viral Testing Market- Recent Developments

    • 6.1 Viral Testing Market News and Developments

    • 6.2 Viral Testing Market Deals Landscape

    7 Viral Testing Raw Materials and Cost Structure Analysis

    • 7.1 Viral Testing Key Raw Materials

    • 7.2 Viral Testing Price Trend of Key Raw Materials

    • 7.3 Viral Testing Key Suppliers of Raw Materials

    • 7.4 Viral Testing Market Concentration Rate of Raw Materials

    • 7.5 Viral Testing Cost Structure Analysis

      • 7.5.1 Viral Testing Raw Materials Analysis

      • 7.5.2 Viral Testing Labor Cost Analysis

      • 7.5.3 Viral Testing Manufacturing Expenses Analysis

    8 Global Viral Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Viral Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Viral Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Viral Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Viral Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Direct Fluorescent Antibody (DFA) Test Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Immunochromatographic Assay Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global RT-PCR-Based Test Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Agglutination Assay Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Flow-Through Assay Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Solid-Phase Assay Consumption and Growth Rate (2017-2022)

    • 9.2 Global Viral Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Laboratory Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic Institute Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Viral Testing Market Analysis and Outlook till 2022

    • 10.1 Global Viral Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Viral Testing Consumption (2017-2022)

      • 10.2.2 Canada Viral Testing Consumption (2017-2022)

      • 10.2.3 Mexico Viral Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Viral Testing Consumption (2017-2022)

      • 10.3.2 UK Viral Testing Consumption (2017-2022)

      • 10.3.3 Spain Viral Testing Consumption (2017-2022)

      • 10.3.4 Belgium Viral Testing Consumption (2017-2022)

      • 10.3.5 France Viral Testing Consumption (2017-2022)

      • 10.3.6 Italy Viral Testing Consumption (2017-2022)

      • 10.3.7 Denmark Viral Testing Consumption (2017-2022)

      • 10.3.8 Finland Viral Testing Consumption (2017-2022)

      • 10.3.9 Norway Viral Testing Consumption (2017-2022)

      • 10.3.10 Sweden Viral Testing Consumption (2017-2022)

      • 10.3.11 Poland Viral Testing Consumption (2017-2022)

      • 10.3.12 Russia Viral Testing Consumption (2017-2022)

      • 10.3.13 Turkey Viral Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Viral Testing Consumption (2017-2022)

      • 10.4.2 Japan Viral Testing Consumption (2017-2022)

      • 10.4.3 India Viral Testing Consumption (2017-2022)

      • 10.4.4 South Korea Viral Testing Consumption (2017-2022)

      • 10.4.5 Pakistan Viral Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh Viral Testing Consumption (2017-2022)

      • 10.4.7 Indonesia Viral Testing Consumption (2017-2022)

      • 10.4.8 Thailand Viral Testing Consumption (2017-2022)

      • 10.4.9 Singapore Viral Testing Consumption (2017-2022)

      • 10.4.10 Malaysia Viral Testing Consumption (2017-2022)

      • 10.4.11 Philippines Viral Testing Consumption (2017-2022)

      • 10.4.12 Vietnam Viral Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Viral Testing Consumption (2017-2022)

      • 10.5.2 Colombia Viral Testing Consumption (2017-2022)

      • 10.5.3 Chile Viral Testing Consumption (2017-2022)

      • 10.5.4 Argentina Viral Testing Consumption (2017-2022)

      • 10.5.5 Venezuela Viral Testing Consumption (2017-2022)

      • 10.5.6 Peru Viral Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Viral Testing Consumption (2017-2022)

      • 10.5.8 Ecuador Viral Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Viral Testing Consumption (2017-2022)

      • 10.6.2 Kuwait Viral Testing Consumption (2017-2022)

      • 10.6.3 Oman Viral Testing Consumption (2017-2022)

      • 10.6.4 Qatar Viral Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Viral Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Viral Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Viral Testing Consumption (2017-2022)

      • 10.7.2 South Africa Viral Testing Consumption (2017-2022)

      • 10.7.3 Egypt Viral Testing Consumption (2017-2022)

      • 10.7.4 Algeria Viral Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Viral Testing Consumption (2017-2022)

      • 10.8.2 New Zealand Viral Testing Consumption (2017-2022)

    11 Global Viral Testing Competitive Analysis

    • 11.1 Wuxi Pharmatech (Cayman)

      • 11.1.1 Wuxi Pharmatech (Cayman) Company Details

      • 11.1.2 Wuxi Pharmatech (Cayman) Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Wuxi Pharmatech (Cayman) Viral Testing Main Business and Markets Served

      • 11.1.4 Wuxi Pharmatech (Cayman) Viral Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Thermo Fisher Scientific

      • 11.2.1 Thermo Fisher Scientific Company Details

      • 11.2.2 Thermo Fisher Scientific Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Thermo Fisher Scientific Viral Testing Main Business and Markets Served

      • 11.2.4 Thermo Fisher Scientific Viral Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 General Electric

      • 11.3.1 General Electric Company Details

      • 11.3.2 General Electric Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 General Electric Viral Testing Main Business and Markets Served

      • 11.3.4 General Electric Viral Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Biospherix

      • 11.4.1 Biospherix Company Details

      • 11.4.2 Biospherix Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Biospherix Viral Testing Main Business and Markets Served

      • 11.4.4 Biospherix Viral Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 BD

      • 11.5.1 BD Company Details

      • 11.5.2 BD Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 BD Viral Testing Main Business and Markets Served

      • 11.5.4 BD Viral Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sartorius

      • 11.6.1 Sartorius Company Details

      • 11.6.2 Sartorius Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sartorius Viral Testing Main Business and Markets Served

      • 11.6.4 Sartorius Viral Testing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bio-Rad Laboratories

      • 11.7.1 Bio-Rad Laboratories Company Details

      • 11.7.2 Bio-Rad Laboratories Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bio-Rad Laboratories Viral Testing Main Business and Markets Served

      • 11.7.4 Bio-Rad Laboratories Viral Testing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Danaher

      • 11.8.1 Danaher Company Details

      • 11.8.2 Danaher Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Danaher Viral Testing Main Business and Markets Served

      • 11.8.4 Danaher Viral Testing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Roche

      • 11.9.1 Roche Company Details

      • 11.9.2 Roche Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Roche Viral Testing Main Business and Markets Served

      • 11.9.4 Roche Viral Testing Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Agilent Technologies

      • 11.10.1 Agilent Technologies Company Details

      • 11.10.2 Agilent Technologies Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Agilent Technologies Viral Testing Main Business and Markets Served

      • 11.10.4 Agilent Technologies Viral Testing Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 QIAGEN International

      • 11.11.1 QIAGEN International Company Details

      • 11.11.2 QIAGEN International Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 QIAGEN International Viral Testing Main Business and Markets Served

      • 11.11.4 QIAGEN International Viral Testing Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Eurofins Scientific

      • 11.12.1 Eurofins Scientific Company Details

      • 11.12.2 Eurofins Scientific Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Eurofins Scientific Viral Testing Main Business and Markets Served

      • 11.12.4 Eurofins Scientific Viral Testing Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Novogene Corporation

      • 11.13.1 Novogene Corporation Company Details

      • 11.13.2 Novogene Corporation Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Novogene Corporation Viral Testing Main Business and Markets Served

      • 11.13.4 Novogene Corporation Viral Testing Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Lonza

      • 11.14.1 Lonza Company Details

      • 11.14.2 Lonza Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Lonza Viral Testing Main Business and Markets Served

      • 11.14.4 Lonza Viral Testing Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Merck

      • 11.15.1 Merck Company Details

      • 11.15.2 Merck Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Merck Viral Testing Main Business and Markets Served

      • 11.15.4 Merck Viral Testing Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Viral Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global Viral Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Direct Fluorescent Antibody (DFA) Test Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Immunochromatographic Assay Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global RT-PCR-Based Test Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Agglutination Assay Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Flow-Through Assay Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Solid-Phase Assay Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Viral Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Academic Institute Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Viral Testing Market Analysis and Outlook to 2028

    • 13.1 Global Viral Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Viral Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Viral Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Viral Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Viral Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK Viral Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Viral Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Viral Testing Consumption Forecast (2022-2028)

      • 13.3.5 France Viral Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Viral Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Viral Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Viral Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Viral Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Viral Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Viral Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Viral Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Viral Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Viral Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Viral Testing Consumption Forecast (2022-2028)

      • 13.4.3 India Viral Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Viral Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Viral Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Viral Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Viral Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Viral Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Viral Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Viral Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Viral Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Viral Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Viral Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Viral Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Viral Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Viral Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Viral Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Viral Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Viral Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Viral Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Viral Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Viral Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Viral Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Viral Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Viral Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Viral Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Viral Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Viral Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Viral Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Viral Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Viral Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Viral Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Viral Testing

    • Figure of Viral Testing Picture

    • Table Global Viral Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Viral Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Direct Fluorescent Antibody (DFA) Test Consumption and Growth Rate (2017-2022)

    • Figure Global Immunochromatographic Assay Consumption and Growth Rate (2017-2022)

    • Figure Global RT-PCR-Based Test Consumption and Growth Rate (2017-2022)

    • Figure Global Agglutination Assay Consumption and Growth Rate (2017-2022)

    • Figure Global Flow-Through Assay Consumption and Growth Rate (2017-2022)

    • Figure Global Solid-Phase Assay Consumption and Growth Rate (2017-2022)

    • Figure Global Laboratory Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Viral Testing Consumption by Country (2017-2022)

    • Table North America Viral Testing Consumption by Country (2017-2022)

    • Figure United States Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Viral Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Viral Testing Consumption by Country (2017-2022)

    • Figure Germany Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure UK Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure France Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Viral Testing Consumption and Growth Rate (2017-2022)

    • Table APAC Viral Testing Consumption by Country (2017-2022)

    • Figure China Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure India Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Viral Testing Consumption and Growth Rate (2017-2022)

    • Table South America Viral Testing Consumption by Country (2017-2022)

    • Figure Brazil Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Viral Testing Consumption and Growth Rate (2017-2022)

    • Table GCC Viral Testing Consumption by Country (2017-2022)

    • Figure Bahrain Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Viral Testing Consumption and Growth Rate (2017-2022)

    • Table Africa Viral Testing Consumption by Country (2017-2022)

    • Figure Nigeria Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Viral Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania Viral Testing Consumption by Country (2017-2022)

    • Figure Australia Viral Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Viral Testing Consumption and Growth Rate (2017-2022)

    • Table Wuxi Pharmatech (Cayman) Company Details

    • Table Wuxi Pharmatech (Cayman) Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuxi Pharmatech (Cayman) Viral Testing Main Business and Markets Served

    • Table Wuxi Pharmatech (Cayman) Viral Testing Product Portfolio

    • Table Thermo Fisher Scientific Company Details

    • Table Thermo Fisher Scientific Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Viral Testing Main Business and Markets Served

    • Table Thermo Fisher Scientific Viral Testing Product Portfolio

    • Table General Electric Company Details

    • Table General Electric Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table General Electric Viral Testing Main Business and Markets Served

    • Table General Electric Viral Testing Product Portfolio

    • Table Biospherix Company Details

    • Table Biospherix Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biospherix Viral Testing Main Business and Markets Served

    • Table Biospherix Viral Testing Product Portfolio

    • Table BD Company Details

    • Table BD Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Viral Testing Main Business and Markets Served

    • Table BD Viral Testing Product Portfolio

    • Table Sartorius Company Details

    • Table Sartorius Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sartorius Viral Testing Main Business and Markets Served

    • Table Sartorius Viral Testing Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Viral Testing Main Business and Markets Served

    • Table Bio-Rad Laboratories Viral Testing Product Portfolio

    • Table Danaher Company Details

    • Table Danaher Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Viral Testing Main Business and Markets Served

    • Table Danaher Viral Testing Product Portfolio

    • Table Roche Company Details

    • Table Roche Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Viral Testing Main Business and Markets Served

    • Table Roche Viral Testing Product Portfolio

    • Table Agilent Technologies Company Details

    • Table Agilent Technologies Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Viral Testing Main Business and Markets Served

    • Table Agilent Technologies Viral Testing Product Portfolio

    • Table QIAGEN International Company Details

    • Table QIAGEN International Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN International Viral Testing Main Business and Markets Served

    • Table QIAGEN International Viral Testing Product Portfolio

    • Table Eurofins Scientific Company Details

    • Table Eurofins Scientific Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eurofins Scientific Viral Testing Main Business and Markets Served

    • Table Eurofins Scientific Viral Testing Product Portfolio

    • Table Novogene Corporation Company Details

    • Table Novogene Corporation Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novogene Corporation Viral Testing Main Business and Markets Served

    • Table Novogene Corporation Viral Testing Product Portfolio

    • Table Lonza Company Details

    • Table Lonza Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Viral Testing Main Business and Markets Served

    • Table Lonza Viral Testing Product Portfolio

    • Table Merck Company Details

    • Table Merck Viral Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Viral Testing Main Business and Markets Served

    • Table Merck Viral Testing Product Portfolio

    • Figure Global Direct Fluorescent Antibody (DFA) Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunochromatographic Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RT-PCR-Based Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Agglutination Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flow-Through Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solid-Phase Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Institute Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Viral Testing Consumption Forecast by Country (2022-2028)

    • Table North America Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure China Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Viral Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia Viral Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Viral Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.